ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lianfang Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0751-1762; OpenAlex author ID A5101586195. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer. Co-author DOI 10.1007/s13577-020-00401-2 ↗
Role of pancreatic stellate cells and periostin in pancreatic cancer progression. First author DOI 10.1007/s13277-015-3386-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yang Liu · 1 shared paper, 2020 · strength 0.15
- Paper ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancr… DOI 10.1007/s13577-020-00401-2 ↗
Peng Qin · 1 shared paper, 2020 · strength 0.15
- Paper ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancr… DOI 10.1007/s13577-020-00401-2 ↗
Fan Li · 1 shared paper, 2020 · strength 0.15
- Paper ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancr… DOI 10.1007/s13577-020-00401-2 ↗
Yang Liu · 1 shared paper, 2015 · strength 0.11
- Paper Role of pancreatic stellate cells and periostin in pancreatic cancer progression. DOI 10.1007/s13277-015-3386-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.